Suggestion de sujets dans votre recherche.
Résultat(s) 1 - 8 résultats de 8 pour la requête '', Temps de recherche: 3,32s Affiner les résultats
  1. 1
    The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease

    Article en ligne

  2. 2
    Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy

    Article en ligne

  3. 3
    HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)

    Article en ligne

  4. 4
    Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease Results from a Phase 1/2 study

    Article en ligne

  5. 5
    Anti-BlyS antibody reduces the immune reaction against enzyme and enhances the efficacy of enzyme replacement therapy in Fabry disease model mice

    Article en ligne

  6. 6
    A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins

    Article en ligne

  7. 7
    BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease

    Article en ligne

  8. 8
    Effects of enzyme replacement therapy on immune function in ADA deficiency patient

    Article en ligne

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel